Replacement | Medicines | 18/11/2010

The marketing authorization holder has informed its supplied customers by letter dated 18.11.2010 that due to 5 complaints about visible particles after reconstitution of the product, which occurred in two batches of this medicinal speciality, the three above mentioned batches will be recalled as a precautionary measure and immediate replacement or

a credit note can be provided.

Name of the medicinal product VELCADE 3,5 mg Pulver zur Herstellung einer Injektionslösung
Marketing authorisation number(s) EU/1/04/274/001
Marketing authorisation holder Janssen-Cilag International NV
Austausch durchgeführt durch Janssen-Cilag Pharma GmbH
Batch number(s) 8EZSQ00, 9FZSK00, 9JZSV00
Classification of the recall2

Further inquiry note